Avita Medical Inc. (51KA)
XBER 
Summary
AVITA Medical, Inc. (RCEL) Discusses Advanced Wound Care Solutions and Data-Driven Approaches in Clinical Healing Transcript
AVITA Medical, Inc. ( RCEL ) Discusses Advanced Wound Care Solutions and Data-Driven Approaches in Clinical Healing November 12, 2025 5:00 PM EST Company Participants Ben Atkins - Vice President of Investor Relations & Corporate Communications Cary Vance - Independent Non-Executive Chairman & Interim CEO Presentation Ben Atkins Vice President of Investor Relations & Corporate Communications [Audio Gap] Cary Vance Independent Non-Executive Chairman & Interim CEO [Audio Gap] In each case, we believe our products are best from a clinical perspective, but also that they speed up the time to graft, the time to heal, which is extremely important for the patient and potential complications, but also important for the hospital that is trying to -- that is striving to make economic progress themselves. And so PermeaDerm is a biosynthetic dressing that protects the wound, that stabilizes the wound.
AVITA Medical, Inc. (RCEL) Q3 2025 Earnings Call Transcript
AVITA Medical, Inc. ( RCEL ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Ben Atkins - Vice President of Investor Relations & Corporate Communications Cary Vance - Independent Non-Executive Chairman & Interim CEO David OToole - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald & Co., Research Division Joshua Jennings - TD Cowen, Research Division Chris Kallos - MST Financial Services Pty Limited, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the AVITA Medical, Inc. Third Quarter 2025 Earnings Conference Call.
AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript
AVITA Medical, Inc. (NASDAQ:RCEL ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Ben Atkins - Corporate Participant David O'Toole - Chief Financial Officer James M. Corbett - CEO, President & Executive Director Conference Call Participants Joshua Thomas Jennings - TD Cowen, Research Division Ross Everett Osborn - Cantor Fitzgerald & Co., Research Division Operator Good day, and thank you for standing by.
Avita Medical Inc. (51KA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Avita Medical Inc. ever had a stock split?
Avita Medical Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Cary G. Vance CEO | XBER Exchange | US05380C1027 ISIN |
| US Country | 260 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
AVITA Medical Inc. is a pioneering commercial-stage regenerative tissue company with operations extending across the United States, Australia, and the United Kingdom. Founded in 2000 and headquartered in Valencia, California, the company specializes in delivering innovative regenerative products aimed at tackling unmet medical needs in various domains, including burn injuries, trauma injuries, chronic wounds, and several dermatological and aesthetic conditions such as vitiligo. Through its patented and proprietary technology, AVITA Medical leverages the regenerative capabilities of a patient's own skin to develop treatments that offer new hope and possibilities in healing. Initially known as AVITA Therapeutics, Inc., the company underwent a name change in December 2020 to better reflect its medical focus and commitment to advancing regenerative medicine.
Products and Services
The cornerstone of AVITA Medical's innovative offerings is the RECELL System, alongside its involvement in promising research collaborations aimed at expanding the potential applications of its regenerative technology:
- RECELL System: This leading-edge device stands out in the field of regenerative medicine by allowing healthcare professionals to produce a suspension of Spray-On Skin cells from a small sample of the patient's own skin. This suspension can then be used in treating acute thermal burns in adult patients aged eighteen years and over. The RECELL System encapsulates the essence of AVITA Medical's mission by harnessing the body's natural healing processes to achieve remarkable recovery outcomes in burn care.
- Research Collaborations: AVITA Medical has entered into vital research collaborations to explore and expand the horizons of regenerative medicine further:
- University of Colorado School of Medicine: This partnership is dedicated to establishing pre-clinical proof-of-concept for a novel spray-on treatment of genetically corrected cells, aiming to push the boundaries of regenerative healing practices.
- Houston Methodist Research Institute: This collaboration seeks to investigate the molecular reversal of cellular aging through a unique cell suspension delivery system, embodying AVITA Medical's commitment to innovation and its potential to revolutionize the field of regenerative medicine.
Contact Information
